These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2518641)
1. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi]. Basombrio MA; Mora MC; Segura MA Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641 [TBL] [Abstract][Full Text] [Related]
2. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice. Basombrío MA; Segura MA; Nasser JR J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102 [TBL] [Abstract][Full Text] [Related]
3. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. Miller MJ; Wrightsman RA; Stryker GA; Manning JE J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953 [TBL] [Abstract][Full Text] [Related]
4. The protective effect of the epimastigote forms of the PF strain of Trypanosoma cruzi against a virulent homologous infection. Menezes H Tropenmed Parasitol; 1976 Dec; 27(4):418-21. PubMed ID: 827037 [TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038 [TBL] [Abstract][Full Text] [Related]
6. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant. Neal RA; Johnson P Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471 [TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: effect of immunization on the risk of vector-delivered infection in guinea pigs. Basombrío MA; Nasser JR; Segura MA; Gomez LE J Parasitol; 1997 Dec; 83(6):1059-62. PubMed ID: 9406779 [TBL] [Abstract][Full Text] [Related]
8. Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum. McHardy N Tropenmed Parasitol; 1977 Jun; 28(2):195-201. PubMed ID: 407684 [TBL] [Abstract][Full Text] [Related]
9. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607 [TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Nickell SP; Sharma D Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388 [TBL] [Abstract][Full Text] [Related]
11. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi. Ruiz AM; Esteva M; Cabeza Meckert P; Laguens RP; Segura EL Acta Trop; 1985 Dec; 42(4):299-309. PubMed ID: 2868632 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice. Kierszenbaum F; Howard JG J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311 [TBL] [Abstract][Full Text] [Related]
13. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: effective dose, time, route, and number of vaccinations. Ritter DM; Rowland EC J Parasitol; 1984 Oct; 70(5):755-9. PubMed ID: 6439845 [TBL] [Abstract][Full Text] [Related]
14. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704 [TBL] [Abstract][Full Text] [Related]
16. Immunization of mice against Trypanosoma cruzi: the effect of chemical treatment or immune serum on an epimastigote vaccine. McHardy N Tropenmed Parasitol; 1978 Jun; 29(2):215-22. PubMed ID: 209592 [TBL] [Abstract][Full Text] [Related]
17. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course]. Introini MV; Basso B; Moretti E Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878 [TBL] [Abstract][Full Text] [Related]
19. Immunization of mice against Trypanosoma cruzi. The effect of size of dose, and route of injection, of immunizing and challenge inocula. McHardy H Tropenmed Parasitol; 1977 Mar; 28(1):11-6. PubMed ID: 404742 [TBL] [Abstract][Full Text] [Related]
20. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]